News

Monday 24th April 2017 (Vienna – Austria) ELITechGroup Symposium (Molecular Diagnostics) : ELITe InGenius® the highly flexible sample-to-result solution (program) ELITechGroup Symposim (Microbiology) : Introducing the Rapid Polymyxin NP™ and Superpolymyxin™ tests, 2 new solutions for detecting and isolating Colistin-resistant strains (program) Contact your local representative for further information.”

Puteaux, France, 27th January 2017 – ELITechGroup Molecular Diagnostics announced today the CE-IVD marking of the Coagulation ELITe MGB® Kit, a high-performance, multiplex assay for the detection of genetic variants associated with higher risk of deep venous thrombosis. Deep venous thrombosis is a multifactorial disease and major health problem which…

Zika ELITe MGB® Kit U.S. and ELITe InGenius, the fully automated sample-to-result system, has joined the fight against the Zika virus. In December, ELITechGroup received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Zika ELITe MGB Kit U.S. used in combination with ELITe InGenius.…

ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB® Kit U.S. performed using the ELITe InGenius™ instrument, a fully automated sample-to-result system. >> Download the press-release“

Puteaux, France, December 9th, 2016 – ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB® Kit U.S. performed using the ELITe InGenius™ instrument, a fully automated sample-to-result system. This real-time PCR-based test utilizes ELITechGroup Molecular Diagnostics…

Puteaux, France November 9th, 2016 – ELITechGroup today announced a U.S. distribution agreement, with Abbott’s Molecular business, for molecular diagnostic reagents. The reagents target a range of genes associated with virus activity in patients that have undergone organ or hematopoietic stem cell transplantation. Additional products included within the agreement focus…

Puteaux, France November 9th, 2016 – ELITechGroup today announced a distribution agreement with Abbott Molecular, Inc. for U.S. distribution of molecular diagnostic reagents. The reagents included in the agreement are focused on monitoring virus activity in patients that have undergone organ or hematopoietic stem cell transplantation. Other products included in…

Puteaux, France November 8th, 2016 – ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB® kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the…

The molecular diagnostics market is one of the fastest-growing segments in the medical diagnostics industry today. According to a study done by DPI Research, the market is projected to reach more than $30 billion by the year 2021. That makes it the largest segment of the in vitro diagnostic (IVD)…

Jan 7, 2015 Matsudo, Japan and Paris, France, January 5, 2015 – Precision System Science, Co., Ltd. (PSS) and The ELITech Group (ELITech) jointly announce that the companies have extended their relationship into a Development and Supply Agreement.Under and an exclusive OEM arrangement, PSS will develop and supply “geneLEADXII” instrument,…